Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ravsted Landsmed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8%   Bankruptcy risk   5.1% 3.2% 3.0% 2.1% 2.4% 2.5% 14.3% 14.0%   Credit score (0-100)   45 55 56 67 63 62 15 16   Credit rating   BBB BBB BBB A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   568 493 544 867 894 571 0.0 0.0   EBITDA   101 139 120 214 244 154 0.0 0.0   EBIT   64.7 93.9 74.7 120 164 56.5 0.0 0.0   Pre-tax profit (PTP)   10.0 72.7 53.7 93.0 131.9 38.1 0.0 0.0   Net earnings   6.9 57.2 29.3 86.3 101.9 27.7 0.0 0.0   Pre-tax profit without non-rec. items   10.0 72.7 53.7 93.0 132 38.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   297 275 463 608 609 617 0.0 0.0   Shareholders equity total   56.9 114 143 230 332 359 309 309   Interest-bearing liabilities   168 154 92.3 125 49.1 50.8 0.0 0.0   Balance sheet total (assets)   504 545 680 1,116 993 860 309 309   Net Debt   120 17.8 39.3 -56.4 1.7 -12.2 -309 -309     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   568 493 544 867 894 571 0.0 0.0   Gross profit growth   0.0% -13.3% 10.5% 59.2% 3.1% -36.1% -100.0% 0.0%   Employees   1 1 1 2 1 1 0 0   Employee growth %   0.0% -14.5% 0.0% 91.0% -25.7% -27.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   504 545 680 1,116 993 860 309 309   Balance sheet change%   0.0% 8.0% 24.8% 64.1% -11.0% -13.5% -64.0% 0.0%   Added value   101.0 139.3 120.3 213.8 258.3 154.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   260 -67 142 50 -78 -91 -617 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.4% 19.1% 13.7% 13.8% 18.4% 9.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.1% 18.5% 12.5% 13.6% 15.8% 6.2% 0.0% 0.0%   ROI %   16.0% 24.0% 16.7% 21.7% 27.4% 9.7% 0.0% 0.0%   ROE %   12.1% 66.9% 22.8% 46.3% 36.3% 8.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   11.3% 20.9% 21.1% 20.6% 33.4% 41.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   118.8% 12.8% 32.7% -26.4% 0.7% -7.9% 0.0% 0.0%   Gearing %   295.6% 134.6% 64.4% 54.4% 14.8% 14.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   66.6% 15.2% 18.5% 27.2% 39.4% 39.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.4 0.6 0.3 0.6 0.7 0.5 0.0 0.0   Current Ratio   0.8 0.9 0.9 0.8 0.9 0.8 0.0 0.0   Cash and cash equivalent   48.1 135.7 52.9 181.3 47.4 63.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -53.4 -31.5 -35.8 -112.7 -37.6 -76.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   86 139 120 112 182 150 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   86 139 120 112 172 150 0 0   EBIT / employee   55 94 75 63 116 55 0 0   Net earnings / employee   6 57 29 45 72 27 0 0